Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
University of California San Diego, Moores Cancer Center, La Jolla, California Moffitt Cancer Center, Tampa, Tampa, Florida University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore, Maryland Harvard Medical School-Massachusetts General Hospital, Boston, Massachusetts M Health Fairview Clinics and Surgery Center, Minneapolis, Minnesota